Life Sciences and Pharma IP 2026

GERMANY Trends and Developments

Trends and Developments Contributed by: Peter Klusmann, Gregor König, Dirk Schüßler-Langeheine and Lasse Christian Weinmann HOFFMANN EITLE

HOFFMANN EITLE is one of the largest intellectual property law firms in Europe with a market-leading, strong presence of 170+ highly qualified, specialised and experienced patent attorneys working across all technical fields. The firm is one of the pioneers of cre ‑ ating a one-stop IP boutique providing outstanding quality services in all areas of intellectual property. No other European firm is entrusted with more EPO opposition cases. HOFFMANN EITLE’s forceful team of passionate litigators has profound experience in patent disputes in all relevant industries, including

pharma and other life sciences, medical devices, tel ‑ ecommunication, automotive, etc. A further strength is its vast expertise in international coordination of multijurisdictional disputes, advising clients regard ‑ ing their overall European litigation strategy. With of ‑ fices in Munich, London, Düsseldorf, Hamburg, Mi ‑ lan, Madrid, Barcelona and Amsterdam, HOFFMANN EITLE is taking the truly European approach, and its attorneys from Japan, the US, China and Korea add a broader international perspective.

Authors

Peter Klusmann is a German and European patent attorney and partner in HOFFMANN EITLE’s chemistry practice group. He has represented small, medium-sized and large clients in all aspects of chemistry and

University of Düsseldorf. He also taught medical engineering patent law at the University of Aachen from 2005 to 2015.

Dirk Schüßler-Langeheine is a qualified attorney-at-law in Germany, UPC Representative and Business Mediator. He is a partner and co-leader of HOFFMANN EITLE’s patent litigation and contracts

beyond for more than two decades. His technical areas range from foods to forest products and from polymers to pharmaceuticals. For the most part, Peter handles contentious matters, particularly opposition and appeal cases before the European Patent Office and revocation actions. Peter has been involved in hundreds of oral proceedings and is very active in patent prosecution and litigation procedures.

practice group. Dirk specializes in patent litigation, with a special focus on life sciences, and frequently acts as German lead counsel and coordinator of pan-European pharma patent enforcement projects for originators. He also advises on licensing and other IP agreements, as well as IP-related aspects of competition law. With his special expertise in the Japanese language and culture, he is regularly involved in the resolution of international disputes involving Japanese companies.

Gregor König is one of the leading German patent attorneys in litigation and validity proceedings and joined HOFFMANN EITLE as a partner in February 2025. During his many years of litigation practice, he has

Lasse Christian Weinmann is a patent attorney and partner in HOFFMANN EITLE’s biotech and

developed special approaches and tools to maximize exclusivity and maintain long-term protection. Gregor represents national and international market leaders in the fields of molecular biology, pharmaceuticals, medical devices, and mechanical engineering. He is currently teaching pharma/biotech patent law at the

pharma practice group and specializes in German nullity proceedings, multinational invalidity and infringement disputes, EPO opposition/appeal cases, the UPC, as well as FTO and invalidity

74 CHAMBERS.COM

Powered by